ORG-201745 is a progestin which was originated by Organon and was under development by Schering-Plough (which acquired Organon in 2007) for the treatment of "female genital diseases" and as a hormonal contraceptive for the prevention of pregnancy but was never marketed.
Attributes | Values |
---|---|
rdf:type | |
rdfs:label |
|
rdfs:comment |
|
dct:subject | |
Wikipage page ID |
|
Wikipage revision ID |
|
Link from a Wikipage to another Wikipage | |
sameAs | |
dbp:wikiPageUsesTemplate | |
CAS number |
|
class | |
has abstract |
|
prov:wasDerivedFrom | |
page length (characters) of wiki page |
|
CAS number |
|
class | |
foaf:isPrimaryTopicOf | |
is Link from a Wikipage to another Wikipage of | |
is Wikipage redirect of | |
is foaf:primaryTopic of |